Form D · Biotechnology

ARROGENE NANOTECHNOLOGY INC

Pacific Palisades, CA · CIK 0001501627

Offering snapshot reported May 2, 2011 · SEC filing

Reported sold
$727K
Offering amount: $727K
Investors reported
45
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 12, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$363K$727KSep 20, 2010Dec 8, 2010: $254,300.00Dec 8, 2010Mar 16, 2011: $496,550.00Mar 16, 2011May 2, 2011: $726,550.00May 2, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$496,550 → $726,550
  • Reported investors33 → 45

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 2, 2011Amendment$726,550$230,000vs Mar 16, 201145SEC filing
Mar 16, 2011Amendment$496,550$242,250vs Dec 8, 201033SEC filing
Dec 8, 2010Amendment$254,300No comparison8SEC filing
Sep 20, 2010InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Debt
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$21.8K
Finders' fees
$0
Form D file number
021-147950
The Maximum Offering was increased by agreement of the Company and the Placement Agent to $726,550. The Maximum Offering closed on April 18, 2011.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
GVC Capital, LLC38923

Source: Form D, filed May 2, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eggehard Holler Director, Executive, Promoter
Alexander Ljubimov Director, Executive, Promoter
Julia Ljubimova Director, Executive, Promoter
Marc Rosenberg Director, Promoter
Robert Stuckelman Director, Executive, Promoter
Maurizio Vecchione Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
15332 Antioch Street 303
Pacific Palisades, CA, 90272